News
Health on MSN2d
Ozempic Users May Face Higher Risk of a Serious Eye DiseaseNew research found a link between GLP-1 use in people with diabetes and an elevated chance of wet AMD, which can cause blindness.
Woman's World on MSN15h
Worried About Your Vision on Ozempic or Wegovy? Read This FirstCan Ozempic or Wegovy Make You Go Blind? What Doctors Want You To Know About the RiskSemaglutide medications like Ozempic and Wegovy have shown proven results for managing conditions like type 2 diabetes and obesity. Also known as GLP-1 agonists, these drugs work by mimicking a ...
Advert Previous studies linked the drug to a rare eye condition known as non-arteritic anterior ischemic optic neuropathy ...
A new study brings into focus the relationship between diabetic GLP-1 users and the elevated risk of age-related eye disease.
A European health authority has found that medications containing semaglutide—such as Ozempic, Wegovy, and Rybelsus—can ...
Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...
Medindia on MSN2d
Diabetes Drug Semaglutide Linked to Vision Loss RiskNew research shows GLP-1 drugs may be linked to a twofold increase in the risk of wet AMD among people with diabetes.
Called non-arteritic anterior ischemic optic neuropathy (NAION), the condition may affect up to 1 in 10,000 people taking semaglutide.
An Israeli study found patients taking Ozempic or similar weight-loss shots were twice as likely to suffer from a serious degenerative eye disease compared ... to a higher risk of kidney cancer ...
The European Medicines Agency has identified a rare eye condition risk linked to Novo Nordisk’s semaglutide drugs.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback